SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028694
Filing Date
2018-11-09
Accepted
2018-11-08 18:52:21
Documents
49
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ttph-10q_20180930.htm 10-Q 1595867
2 EX-31.1 ttph-ex311_8.htm EX-31.1 17283
3 EX-31.2 ttph-ex312_6.htm EX-31.2 17541
4 EX-32.1 ttph-ex321_9.htm EX-32.1 6211
5 EX-32.2 ttph-ex322_7.htm EX-32.2 6496
  Complete submission text file 0001564590-18-028694.txt   4712060

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ttph-20180930.xml EX-101.INS 766839
7 XBRL TAXONOMY EXTENSION SCHEMA ttph-20180930.xsd EX-101.SCH 41954
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttph-20180930_cal.xml EX-101.CAL 25534
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttph-20180930_def.xml EX-101.DEF 143293
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttph-20180930_lab.xml EX-101.LAB 319976
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttph-20180930_pre.xml EX-101.PRE 235430
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35837 | Film No.: 181171028
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1